Publications of U. Reichl
All genres
Meeting Abstract (45)
2010
Meeting Abstract
82 (9 - Special Issue : ProcessNet-Jahrestagung 2010 und 28. Jahrestagung der Biotechnologen), p. 1496. ProcessNet-Jahrestagung 2010 und 28. Jahrestagung der Biotechnologen, Aachen, Germany, September 21, 2010 - September 23, 2010. (2010)
Virus-Wirtszell-Interaktion bei der Produktion von Influenza A Impfstoff in tierischer Zellkultur: Änderungen des Proteoms von Produktionszelllinien. In Chemie Ingenieur Technik, 2009
Meeting Abstract
81 (8), p. 1241 . ProcessNet-Jahrestagung 2009 und 27. Jahrestagung der Biotechnologen, Mannheim, Germany, September 08, 2009 - September 10, 2009. Verlag Chemie, GmbH, Weinheim, Germany (2009)
Numerische und experimentelle Untersuchung der Fließbedingungen in Wave-Bioreaktoren. In Chemie-Ingenieur-Technik, 2006
Meeting Abstract
Metabolic Flux Analysis of MDCK Cells in Glutamine-Containing and Glutamine-Free Culture Media. In Metabolic Engineering VI: Program, p. 102. Metabolic Engineering IV, Noordwijkerhout, The Netherlands, October 01, 2006 - October 05, 2006. (2006)
Meeting Abstract
Stochastic Population Balance Modeling of Influenza Virus replication in a Vaccine Production Process. In Conference Proceedings / AIChE annual meeting 2006, p. 622f. AIChE annual meeting 2006, San Francisco, USA, November 12, 2006 - November 17, 2006. (2006)
2004
Meeting Abstract
A Mathematical Model for the Replication of Influenza A Virus. In BioPerspective 2004: mit 22. DECHEMA-Jahrestagung der Biotechnologen: Kurzfassungen, p. 82. BioPerspective 2004 : mit 22. DECHEMA-Jahrestagung der Biotechnologen, Wiesbaden, Germany, May 04, 2004 - May 06, 2004. (2004)
Meeting Abstract
A Model for the Influenza Virus Live-Cycle in a Single Cell. In ICSB: 5th International Congress on Systems Biology: Book of abstracts, p. 382. ICSB : 5th International Congress on Systems Biology, Heidelberg, Germany, October 09, 2004 - October 13, 2004. (2004)
2002
Meeting Abstract
74 (5), pp. 661 - 662. GVC DECHEMA Jahrestagung, Wiesbaden, Germany, June 11, 2002 - June 13, 2002. (2002)
Mathematical Model of Virus Replication in Animal Cells. In Chemie Ingenieur Technik,
Meeting Abstract
Validation of a T-RFLP Technique for the Precise Qualitative and Quantitative Characterization of Microbioal Communities by Using an Automated High Throughput Multi-Capillary Electrophoresis Device. In Abstracts of the General Meeting of the American Society for Microbiology, N-102, p. 323. 102nd General Meeting of the American Society for Microbiology, Salt Lake City, USA, May 19, 2002 - May 23, 2002. (2002)
Talk (266)
2025
Talk
Influenza Vector-Based Defective Interfering Particles for Use as Broad-Spectrum Antiviral and Mucosal Live Vaccine: Construction, Production and in Vivo Efficacy. 34th Annual Meeting of the Society for Virology, Hamburg (Germany) (2025)
Talk
Engineered influenza vectors for use as broadly-acting antivirals and live nasal vaccines: design, manufacture and in vivo efficacy. 9th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)
Talk
Expanding Glycoproteomics: Including N-Glycopeptides Bearing Glucuronidated, O-Acetylated or Sulfated N-Glycans in the Analysis of Human Serum Proteins such as Immunoglobulin A. GlycoBioTec 2025, Berlin (Germany) (2025)
2024
Talk
A cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimization. 6th MECP (Multistep Enzyme Catalyzed Processes) Congress, Vienna (Austria) (2024)
Talk
Shaking to very high cell densities - perfusion for virus production. Kuhner Large Scale Meeting, Girona (Spain) (2024)
Talk
Next-generation virus production: from clone, to AMBR, to perfusion and very high virus yield. 8th Edition of the "International Symposium on Immunobiologicals" (8th ISI), Rio de Janeiro (Brazil) (2024)
Talk
Engineered defective interfering particles of influenza A virus for antiviral treatment. 33rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)
Talk
Genetic engineering of Influenza A virus defective interfering particles towards improved antiviral efficacy and potential use as a live vaccine. Vaccine Technology IX, Los Cabos (Mexico) (2024)
Talk
A two-dimensional model to predict influenza virus and defective interfering particle coinfection in tissue-like systems. 28th ESACT Meeting, Edingburgh (Scotland) (2024)
Talk
Predicting the antiviral efficacy of defective interfering particles against influenza virus infection in tissues. KSMB-SMB 2024, Seoul (South Korea) (2024)
Talk
Influenza A Virus Production following Quality by Design Principles. Vaccine Technology IX, Los Cabos (Mexico) (2024)
Talk
Discovering Rare Sialylated N glycans Holding O Acetylation or Sulfation within the Site-Specific N glycosylation of Human Serum IgA. SialoGlyco 2024 (International Conference in SialoGlycobiology 2024), Lille (France) (2024)